Literature DB >> 25564122

Health care-associated methicillin-resistant Staphylococcus aureus infections increases the risk of postdischarge mortality.

Richard E Nelson1, Vanessa W Stevens2, Makoto Jones3, Matthew H Samore3, Michael A Rubin3.   

Abstract

BACKGROUND: Although many studies have estimated the impact of health care-associated methicillin-resistant Staphylococcus aureus (MRSA) infections on mortality during initial hospitalization, little is known about the long-term risk of death in these patients. The purpose of this study was to quantify the effect of MRSA health care-acquired infections (HAIs) on mortality after hospital discharge.
METHODS: Our study cohort consisted of patients with inpatient admission within the U.S. Department of Veterans Affairs system between October 1, 2007, and September 30, 2010. Of these patients, we identified those with a positive MRSA culture from electronic microbiology reports. We constructed multivariable Cox proportional hazards regressions to assess the impact of a positive culture on postdischarge mortality in the 365 days following discharge using both the full cohort and a propensity score-matched subsample.
RESULTS: In our analysis cohort of 369,743 inpatients, positive MRSA cultures were recorded in 3,599 (1.0%) patients. We found that positive cultures resulted in an increased risk of postdischarge mortality both in the full cohort (hazard ratio = 1.42, P < .001) and in the subset of propensity score-matched patients (hazard ratio = 1.37, P < .0001).
CONCLUSION: We found that MRSA HAIs significantly elevate the long-term risk of mortality. These results underscore the importance of infection prevention efforts in the hospital. Published by Elsevier Inc.

Entities:  

Keywords:  Health care–associated infection; Methicillin-resistant Staphylococcus aureus; Mortality; Veterans affairs

Mesh:

Year:  2015        PMID: 25564122     DOI: 10.1016/j.ajic.2014.09.014

Source DB:  PubMed          Journal:  Am J Infect Control        ISSN: 0196-6553            Impact factor:   2.918


  7 in total

1.  Economic Analysis of Veterans Affairs Initiative to Prevent Methicillin-Resistant Staphylococcus aureus Infections.

Authors:  Richard E Nelson; Vanessa W Stevens; Karim Khader; Makoto Jones; Matthew H Samore; Martin E Evans; R Douglas Scott; Rachel B Slayton; Marin L Schweizer; Eli L Perencevich; Michael A Rubin
Journal:  Am J Prev Med       Date:  2016-05       Impact factor: 5.043

2.  A Longitudinal Study of S. aureus Infection in a National Cohort of Surgical Patients.

Authors:  William J O'Brien; Kalpana Gupta; Kamal M F Itani
Journal:  Open Forum Infect Dis       Date:  2019-08-13       Impact factor: 3.835

3.  Host-Pathogen-Treatment Triad: Host Factors Matter Most in Methicillin-Resistant Staphylococcus aureus Bacteremia Outcomes.

Authors:  M Cristina Vazquez Guillamet; Rodrigo Vazquez; Benjamin Deaton; Jenny Shroba; Laia Vazquez; Renee-Claude Mercier
Journal:  Antimicrob Agents Chemother       Date:  2018-01-25       Impact factor: 5.191

4.  Prevalence and characteristics of Staphylococcus aureus and methicillin-resistant Staphylococcus aureus nasal colonization among a community-based diabetes population in Foshan, China.

Authors:  Jialing Lin; Ping Xu; Yang Peng; Dongxin Lin; Qianting Ou; Ting Zhang; Chan Bai; Xiaohua Ye; Junli Zhou; Zhenjiang Yao
Journal:  J Diabetes Investig       Date:  2016-12-15       Impact factor: 4.232

5.  Estimating the burden of antimicrobial resistance: a systematic literature review.

Authors:  Nichola R Naylor; Rifat Atun; Nina Zhu; Kavian Kulasabanathan; Sachin Silva; Anuja Chatterjee; Gwenan M Knight; Julie V Robotham
Journal:  Antimicrob Resist Infect Control       Date:  2018-04-25       Impact factor: 4.887

6.  Methicillin-resistant Staphylococcus aureus nasal colonization and infection in an intensive care unit of a university hospital in China.

Authors:  Fu Qiao; Wenzhi Huang; Lin Cai; Zhiyong Zong; Weijia Yin
Journal:  J Int Med Res       Date:  2018-06-18       Impact factor: 1.671

7.  Mortality, Length of Stay, and Healthcare Costs Associated With Multidrug-Resistant Bacterial Infections Among Elderly Hospitalized Patients in the United States.

Authors:  Richard E Nelson; David Hyun; Amanda Jezek; Matthew H Samore
Journal:  Clin Infect Dis       Date:  2022-03-23       Impact factor: 9.079

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.